Literature DB >> 27241049

Incidence and causes of silent and symptomatic stroke following surgical and transcatheter aortic valve replacement: a comprehensive review.

Stephanie Grabert1, Rüdiger Lange2, Sabine Bleiziffer2.   

Abstract

Stroke associated with aortic valve replacement in calcific aortic stenosis, either via transcatheter implantation (TAVR) or via surgical replacement (SAVR), is one of the most devastating complications. However, data concerning the clinical impact and incidence of clinical and silent stroke complicating SAVR and TAVR are varying. This comprehensive review of the literature explores the genuine incidence of neurological events after these procedures. Additionally, potential factors responsible for the discrepancies in stroke rates in the current literature are analysed and a lack of uniform neurological definitions and standardized neurological assessments revealed. Current stroke rates after TAVR show a decline from 7 to 1.7-4.8% in recent studies. Randomized studies comparing TAVR with SAVR yielded initially a significantly higher stroke rate after TAVR procedures as opposed to SAVR. Recently published data showed opposite results with strokes being higher following SAVR. Current data concerning stroke after surgical valve replacement report significantly higher rates of clinical strokes (17%) than previously mentioned in the literature (≤4.9%). Silent cerebral lesions were detected in 68-93% after TAVR and 38-54% after SAVR. A broader application of cerebral protection devices may help to reduce embolic cerebral events.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; Cognitive dysfunction; Ischaemic infarction; Stroke; Surgical aortic valve replacement; Transcatheter aortic valve replacement

Mesh:

Year:  2016        PMID: 27241049     DOI: 10.1093/icvts/ivw142

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  6 in total

Review 1.  Transcatheter aortic valve replacement and stroke: a comprehensive review.

Authors:  Periklis A Davlouros; Virginia C Mplani; Ioanna Koniari; Grigorios Tsigkas; George Hahalis
Journal:  J Geriatr Cardiol       Date:  2018-01       Impact factor: 3.327

Review 2.  Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis.

Authors:  Michael K Wang; Pascal B Meyre; Rachel Heo; P J Devereaux; Lauren Birchenough; Richard Whitlock; William F McIntyre; Yu Chiao Peter Chen; Muhammad Zain Ali; Fausto Biancari; Jawad Haider Butt; Jeff S Healey; Emilie P Belley-Côté; Andre Lamy; David Conen
Journal:  CJC Open       Date:  2021-09-16

3.  Actual incidence of cerebral infarction after thoracic endovascular aortic repair: a magnetic resonance imaging study.

Authors:  Sohsyu Kotani; Yoshito Inoue; Naohiko Oki; Hideki Yashiro; Takashi Hachiya
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18

4.  New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohort.

Authors:  Ofir Koren; Vivek Patel; Robert Naami; Edmund Naami; Takashi Nagasaka; Alon Shechter; Sharon Shalom Natanzon; Siamak Kohan; Zev Allison; Addee Lerner; Daniel Eugene Cheng; Tarun Chakravarty; Mamoo Nakamura; Wen Cheng; Hasan Jilaihawi; Raj R Makkar
Journal:  Front Cardiovasc Med       Date:  2022-09-21

5.  Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set.

Authors:  Laura Stein; Alison Thaler; John W Liang; Stanley Tuhrim; Amit S Dhamoon; Mandip S Dhamoon
Journal:  J Am Heart Assoc       Date:  2017-12-02       Impact factor: 5.501

Review 6.  Asymptomatic Stroke in the Setting of Percutaneous Non-Coronary Intervention Procedures.

Authors:  Giovanni Ciccarelli; Francesca Renon; Renato Bianchi; Donato Tartaglione; Maurizio Cappelli Bigazzi; Francesco Loffredo; Paolo Golino; Giovanni Cimmino
Journal:  Medicina (Kaunas)       Date:  2021-12-28       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.